| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13637* | 2021 |
| Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy AM Cuervo, L Stefanis, R Fredenburg, PT Lansbury, D Sulzer Science 305 (5688), 1292-1295, 2004 | 2499 | 2004 |
| α-Synuclein in Parkinson's disease L Stefanis Cold Spring Harbor perspectives in medicine 2 (2), a009399, 2012 | 1761 | 2012 |
| Cell-produced α-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival E Emmanouilidou, K Melachroinou, T Roumeliotis, SD Garbis, M Ntzouni, ... Journal of Neuroscience 30 (20), 6838-6851, 2010 | 1320 | 2010 |
| Wild type α-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells T Vogiatzi, M Xilouri, K Vekrellis, L Stefanis Journal of Biological Chemistry 283 (35), 23542-23556, 2008 | 817 | 2008 |
| Expression of A53T mutant but not wild-type α-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and … L Stefanis, KE Larsen, HJ Rideout, D Sulzer, LA Greene Journal of Neuroscience 21 (24), 9549-9560, 2001 | 760 | 2001 |
| Autophagy and its possible roles in nervous system diseases, damage and repair DC Rubinsztein, M DiFiglia, N Heintz, RA Nixon, ZH Qin, B Ravikumar, ... Autophagy 1 (1), 11-22, 2005 | 562 | 2005 |
| α-Synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis KE Larsen, Y Schmitz, MD Troyer, E Mosharov, P Dietrich, AZ Quazi, ... Journal of Neuroscience 26 (46), 11915-11922, 2006 | 550 | 2006 |
| Pathological roles of α-synuclein in neurological disorders K Vekrellis, M Xilouri, E Emmanouilidou, HJ Rideout, L Stefanis The Lancet Neurology 10 (11), 1015-1025, 2011 | 486 | 2011 |
| The Parkinson's progression markers initiative (PPMI)–establishing a PD biomarker cohort K Marek, S Chowdhury, A Siderowf, S Lasch, CS Coffey, ... Annals of clinical and translational neurology 5 (12), 1460-1477, 2018 | 477 | 2018 |
| Abberant α-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy M Xilouri, T Vogiatzi, K Vekrellis, D Park, L Stefanis PloS one 4 (5), e5515, 2009 | 430 | 2009 |
| Proteasomal inhibition leads to formation of ubiquitin/α‐synuclein‐immunoreactive inclusions in PC12 cells HJ Rideout, KE Larsen, D Sulzer, L Stefanis Journal of neurochemistry 78 (4), 899-908, 2001 | 383 | 2001 |
| Alpha-synuclein and protein degradation systems: a reciprocal relationship M Xilouri, OR Brekk, L Stefanis Molecular neurobiology 47 (2), 537-551, 2013 | 367 | 2013 |
| Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study OA Ross, AI Soto-Ortolaza, MG Heckman, JO Aasly, N Abahuni, G Annesi, ... The Lancet Neurology 10 (10), 898-908, 2011 | 356 | 2011 |
| α-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells XM Peng, R Tehranian, P Dietrich, L Stefanis, RG Perez Journal of cell science 118 (15), 3523-3530, 2005 | 355 | 2005 |
| Autophagy and A lpha‐S ynuclein: R elevance to P arkinson's D isease and R elated S ynucleopathies M Xilouri, OR Brekk, L Stefanis Movement Disorders 31 (2), 178-192, 2016 | 322 | 2016 |
| Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress DS Park, EJ Morris, L Stefanis, CM Troy, ML Shelanski, HM Geller, ... Journal of Neuroscience 18 (3), 830-840, 1998 | 301 | 1998 |
| Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study KM Moore, J Nicholas, M Grossman, CT McMillan, DJ Irwin, L Massimo, ... The Lancet Neurology 19 (2), 145-156, 2020 | 297 | 2020 |
| Cell-produced α-synuclein oligomers are targeted to, and impair, the 26S proteasome E Emmanouilidou, L Stefanis, K Vekrellis Neurobiology of aging 31 (6), 953-968, 2010 | 293 | 2010 |
| Postmortem cortex samples identify distinct molecular subtypes of ALS: retrotransposon activation, oxidative stress, and activated glia OH Tam, NV Rozhkov, R Shaw, D Kim, I Hubbard, S Fennessey, N Propp, ... Cell reports 29 (5), 1164-1177. e5, 2019 | 267 | 2019 |
